search
Back to results

Feasibility and Usability of COVID-19 Antigen RDTs in Uganda

Primary Purpose

COVID-19 Pandemic

Status
Recruiting
Phase
Not Applicable
Locations
Uganda
Study Type
Interventional
Intervention
PMC Sure Status COVID-19 Antigen Test
Acon Flowflex COVID-19 Antigen Home Test
Sponsored by
PATH
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for COVID-19 Pandemic

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

OPD patients (index cases) for professional use testing Inclusion Criteria: 18 years of age or older or below 18 years and meets the qualification of an emancipated minor (heads a family, takes care of his/herself, pregnant/has children, cohabiting or married). Exhibits signs and symptoms of a COVID-19 infection. Positive screening result for COVID-19 infection using -Ag-RDT self-test or Ag-RDT professional-use test. Willing and able to provide informed consent to participate and comply with study requirements. Exclusion Criteria: Any study site employees who are involved in the protocol or may have access to study-related data. Treating clinician deems inappropriate to enroll. Those who do not have a telephone contact to report results and be interviewed on phone. Household contacts of OPD patients for self-testing Inclusion Criteria: 18 years of age or older or below 18 years and meets the qualification of an emancipated minor (heads a family, takes care of his/herself, pregnant/has children, cohabiting or married). Exposure to COVID-19 (i.e., being within 6ft/1 meter of the index case for more than 15 minutes or physical contact with the index case within the 2 days before symptom onset of the confirmed COVID-19 case (index case). Willing and able to provide informed consent. Exclusion Criteria Contraindication to nasal swab. Had a nasopharyngeal swab in the last 8 hours. Any study site employees who are involved in the protocol or may have access to study-related data. Already enrolled in this study. Community-based self-testing participants (FSWs and Boda boda drivers) Inclusion criteria: 18 years of age or older or below 18 years and meets the qualification of an emancipated minor (heads a family, takes care of his/herself, pregnant/has children, cohabiting or married). Must identify as a FSW or Boda boda driver. Ability to provide informed consent. Must be a resident or working in Kampala or Luwero districts. Exclusion Criteria: Unwilling or unable to provide informed consent. Not a part of the population group outlined above. Has no cell phone to convey results and for interview.

Sites / Locations

  • Kisenyi Health Center IVRecruiting
  • Kiswa Health Center IIIRecruiting
  • Katikamu Health Center IIIRecruiting
  • Luwero HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

No Intervention

Arm Label

Facility-based Ag-RDT COVID-19 testing - reactive

Facility-based Ag-RDT COVID-19 testing - non-reactive

COVID-19 Ag-RDT self-testing - agree to self-test

COVID-19 Ag-RDT self-testing - refuse to self-test

Arm Description

Out-patient department patients who utilized a COVID-19 Ag-RDT professional-use test in an OPD clinical setting with reactive test result

Out-patient department patients who utilized a COVID-19 Ag-RDT professional-use test in an OPD clinical setting with non-reactive test result

Participants who receive and take a COVID-19 Ag-RDT self-test (female sex workers, Boda boda drivers, household contacts)

Participants who receive but refuse to take a COVID-19 Ag-RDT self-test (female sex workers, Boda boda drivers, household contacts)

Outcomes

Primary Outcome Measures

Implementation success
Proportion of focus group discussion responses on the barriers, facilitators, user preferences, and acceptability to offering COVID-19 Ag-RDT professional and self-administered kits in health facilities and community settings through thematic analysis.
Demand - OPD
Proportion of COVID-19 OPD cases identified via professional use testing who accept self-testing kits for their contacts.
Demand - Community
Proportion of FSWs, Boda boda drivers, and household contacts who use Ag-RDT COVID-19 self-tests and report their results.

Secondary Outcome Measures

Usability
Proportion of assisted self-testers compared to unassisted self-testers who self-report their comfort with correctly using the test and return the results, stratified by population group (OPD patients, household contacts of OPD patients, FSWs, and Boda boda drivers).

Full Information

First Posted
November 21, 2022
Last Updated
April 19, 2023
Sponsor
PATH
search

1. Study Identification

Unique Protocol Identification Number
NCT05630300
Brief Title
Feasibility and Usability of COVID-19 Antigen RDTs in Uganda
Official Title
Assessing the Feasibility and Usability of Implementing Professional Use and Self-administered COVID-19 Antigen RDTs in Uganda
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
March 1, 2023 (Actual)
Primary Completion Date
September 1, 2023 (Anticipated)
Study Completion Date
September 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
PATH

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This study will assess the feasibility and usability of COVID-19 professional and self-administered Antigen-Rapid Diagnostic Tests (Ag-RDTs) through health facility outpatient services and community settings in Kampala and Luwero districts in Uganda. There are two components to this study: Facility-based COVID-19 Ag-RDT professional use testing which will include people seeking care at outpatient departments and household contacts of index participants diagnosed at outpatient departments in four health facilities in Kampala and Luwero districts. Community-based COVID-19 Ag-RDT self-testing which will include at-risk populations such as female sex workers (FSW) and Boda boda drivers (motorcyclists) at points of mass throughfare in Kampala and Luwero districts. Key outcomes target the implementation's success, demand, and usability of professional and self-administered Ag-RDTs.
Detailed Description
This study seeks to understand the feasibility and usability of COVID-19 Ag-RDT self-tests among Boda boda drivers and FSWs in community-based settings in two districts of Uganda. Ag-RDT COVID-19 professional use tests will also be assessed, among patients soliciting OPD services in health facilities, to support public-sector screening when qRT-PCR testing services are limited or unavailable. Feasibility for the purposes of this intervention refers to core factors affecting implementation success (i.e., barriers, facilitators, user preferences, and acceptability of Ag-RDT use and implementation) and demand (the measure of actual use of professional and self-administered Ag-RDTs in the population). Usability is defined as the extent to which FSWs, Boda boda drivers, and OPD patients, and household contacts of OPD patients self-report their comfort with performing critical self-testing procedures (sample collection, sample processing, and results interpretation) autonomously. Primary Research Objective • To assess the feasibility of using professional and self-administered COVID-19 Ag-RDTs in facility OPD and community settings in Uganda. Secondary Research Objective • Determine usability of Ag-RDT COVID-19 self-tests among FSWs, Boda boda drivers, OPD patients, and household contacts of OPD patients. Primary outcomes: Feasibility of professional and self-administered COVID-19 Ag-RDT use. Implementation success. Number of people who report COVID 19 self-testing and professional COVID 19 testing acceptable and preferred. Demand. Proportion of COVID-19 OPD cases identified via professional use testing who accept to take self-testing kits for their contacts. Demand. Proportion of FSWs, Boda boda drivers, and household contacts who use Ag-RDT COVID-19 self-tests and report their findings. Secondary outcomes: Usability of Ag-RDT self-administered tests. • Usability. Proportion of assisted self-testers compared to unassisted self-testers who self-report that they feel comfortable using the test and return the results, stratified by population group (OPD patients, household contacts of OPD patients, FSWs, and Boda boda drivers).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19 Pandemic

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
1460 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Facility-based Ag-RDT COVID-19 testing - reactive
Arm Type
Experimental
Arm Description
Out-patient department patients who utilized a COVID-19 Ag-RDT professional-use test in an OPD clinical setting with reactive test result
Arm Title
Facility-based Ag-RDT COVID-19 testing - non-reactive
Arm Type
Experimental
Arm Description
Out-patient department patients who utilized a COVID-19 Ag-RDT professional-use test in an OPD clinical setting with non-reactive test result
Arm Title
COVID-19 Ag-RDT self-testing - agree to self-test
Arm Type
Experimental
Arm Description
Participants who receive and take a COVID-19 Ag-RDT self-test (female sex workers, Boda boda drivers, household contacts)
Arm Title
COVID-19 Ag-RDT self-testing - refuse to self-test
Arm Type
No Intervention
Arm Description
Participants who receive but refuse to take a COVID-19 Ag-RDT self-test (female sex workers, Boda boda drivers, household contacts)
Intervention Type
Diagnostic Test
Intervention Name(s)
PMC Sure Status COVID-19 Antigen Test
Intervention Description
COVID-19 professional use kit in out-patient departments
Intervention Type
Diagnostic Test
Intervention Name(s)
Acon Flowflex COVID-19 Antigen Home Test
Intervention Description
COVID-19 self-test kits
Primary Outcome Measure Information:
Title
Implementation success
Description
Proportion of focus group discussion responses on the barriers, facilitators, user preferences, and acceptability to offering COVID-19 Ag-RDT professional and self-administered kits in health facilities and community settings through thematic analysis.
Time Frame
6 months
Title
Demand - OPD
Description
Proportion of COVID-19 OPD cases identified via professional use testing who accept self-testing kits for their contacts.
Time Frame
6 months
Title
Demand - Community
Description
Proportion of FSWs, Boda boda drivers, and household contacts who use Ag-RDT COVID-19 self-tests and report their results.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Usability
Description
Proportion of assisted self-testers compared to unassisted self-testers who self-report their comfort with correctly using the test and return the results, stratified by population group (OPD patients, household contacts of OPD patients, FSWs, and Boda boda drivers).
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
OPD patients (index cases) for professional use testing Inclusion Criteria: 18 years of age or older or below 18 years and meets the qualification of an emancipated minor (heads a family, takes care of his/herself, pregnant/has children, cohabiting or married). Exhibits signs and symptoms of a COVID-19 infection. Positive screening result for COVID-19 infection using -Ag-RDT self-test or Ag-RDT professional-use test. Willing and able to provide informed consent to participate and comply with study requirements. Exclusion Criteria: Any study site employees who are involved in the protocol or may have access to study-related data. Treating clinician deems inappropriate to enroll. Those who do not have a telephone contact to report results and be interviewed on phone. Household contacts of OPD patients for self-testing Inclusion Criteria: 18 years of age or older or below 18 years and meets the qualification of an emancipated minor (heads a family, takes care of his/herself, pregnant/has children, cohabiting or married). Exposure to COVID-19 (i.e., being within 6ft/1 meter of the index case for more than 15 minutes or physical contact with the index case within the 2 days before symptom onset of the confirmed COVID-19 case (index case). Willing and able to provide informed consent. Exclusion Criteria Contraindication to nasal swab. Had a nasopharyngeal swab in the last 8 hours. Any study site employees who are involved in the protocol or may have access to study-related data. Already enrolled in this study. Community-based self-testing participants (FSWs and Boda boda drivers) Inclusion criteria: 18 years of age or older or below 18 years and meets the qualification of an emancipated minor (heads a family, takes care of his/herself, pregnant/has children, cohabiting or married). Must identify as a FSW or Boda boda driver. Ability to provide informed consent. Must be a resident or working in Kampala or Luwero districts. Exclusion Criteria: Unwilling or unable to provide informed consent. Not a part of the population group outlined above. Has no cell phone to convey results and for interview.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Justine Komunyena Tumusiime
Phone
+256772661226
Email
Jtumusiime@path.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kimberly Green
Organizational Affiliation
PATH
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kisenyi Health Center IV
City
Kampala
State/Province
Central
ZIP/Postal Code
7404
Country
Uganda
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Justine Tumusiime Komunyena, MPH
Phone
0772661226
Email
jtumusiime@path.org
First Name & Middle Initial & Last Name & Degree
Kimberly Green, PHD
Phone
0772661226
Email
kgreen@path.org
Facility Name
Kiswa Health Center III
City
Kampala
State/Province
Central
ZIP/Postal Code
7404
Country
Uganda
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Justine Tumusiime Komunyena, MPH
Phone
0772661226
Email
jtumusiime@path.org
First Name & Middle Initial & Last Name & Degree
Derrick Mimbe, MPH
Phone
0776841039
Email
dmimbe@path.org
Facility Name
Katikamu Health Center III
City
Luwero
State/Province
Central
ZIP/Postal Code
7404
Country
Uganda
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Justine Tumusiime Komunyena, MPH
Phone
0772661226
Email
jtumusiime@path.org
First Name & Middle Initial & Last Name & Degree
Derrick Mimbe, MPH
Phone
0776841039
Email
dmimbe@path.org
Facility Name
Luwero Hospital
City
Luwero
State/Province
Central
ZIP/Postal Code
7404
Country
Uganda
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Justine Tumusiime Komunyena, MPH
Phone
0772661226
Email
jtumusiime@path.org
First Name & Middle Initial & Last Name & Degree
Derrick Mimbe, MPH
Phone
0776841039
Email
dmimbe@path.org

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
The investigators do not plan to share any individual participant data, as study data will be aggregated into the study database for analysis and further dissemination of results.

Learn more about this trial

Feasibility and Usability of COVID-19 Antigen RDTs in Uganda

We'll reach out to this number within 24 hrs